Health ❯Pharmaceuticals ❯Drug Development

Weight Loss Drugs

Zepbound CagriSema

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

Eli Lilly Targets Unapproved Weight-Loss Drugs with New Ad Campaign